The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
Author:
Publisher
Elsevier
Reference51 articles.
1. Polyglutamine disease modeling: Epitope based screen for homologous recombination using CRISPR/Cas9 system;An;PLoS Currents,2014
2. Microhomology-based choice of Cas9 nuclease target sites;Bae;Nature Methods,2014
3. Breaking the code of DNA binding specificity of TAL-type III effectors;Boch;Science,2009
4. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting;Cermak;Nucleic Acids Research,2011
5. Chemically defined conditions for human iPSC derivation and culture;Chen;Nature Methods,2011
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction;Science Advances;2024-06-07
2. “Time Is out of Joint” in Pluripotent Stem Cells: How and Why;International Journal of Molecular Sciences;2024-02-08
3. Novelty in improvement of CAR T cell-based immunotherapy with the aid of CRISPR system;Hematology, Transfusion and Cell Therapy;2023-07
4. PDGF Receptors and Signaling Are Required for 3D-Structure Formation and Differentiation of Human iPSC-Derived Hepatic Spheroids;International Journal of Molecular Sciences;2023-04-11
5. Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3